Menu

Sensei Biotherapeutics Reports Q3 2025 Financial Results and Announces Discontinuation of Solnerstotug Development

Article |

SigmaBee1828k 7mo ago
Sensei Biotherapeutics Reports Q3 2025 Financial Results and Announces Discontinuation of Solnerstotug Development

Sensei Biotherapeutics discontinues solnerstotug development, reviews strategic alternatives, and reduces workforce by 65% amid financial...

Comments (0)

Newest

No comments yet.